A phase II clinical trial of neoadjuvant chemotherapy combined with immunotherapy and different radiotherapy fractionation regimens in HR+/HER2- breast cancer - Quiz - MDSpire

A phase II clinical trial of neoadjuvant chemotherapy combined with immunotherapy and different radiotherapy fractionation regimens in HR+/HER2- breast cancer

  • By

  • Jie Lan

  • Xiaoyue Sun

  • Xiaobo Huang

  • Yanxia Zhao

  • Zhuofei Bi

  • Wei Huang

  • Tin Luo

  • Jing Jing

  • Xin Wu

  • Lei Liu

  • July 9, 2026

  • 0 min

Share

Original Source(s)

A phase II clinical trial of neoadjuvant chemotherapy combined with immunotherapy and different radiotherapy fractionation regimens in HR+/HER2- breast cancer

  • by Jie Lan, Xiaoyue Sun, Xiaobo Huang, Yanxia Zhao, Zhuofei Bi, Wei Huang, Tin Luo, Jing Jing, Xin Wu, Lei Liu

  • July 9, 2026

Related Content

Sequential gemcitabine–docetaxel in BCG-naïve and BCG-failure non–muscle-invasive bladder cancer: a systematic review and meta-analysis

Eight-year disease-free survival in clear cell adenocarcinoma of the urethra with surgery alone: a case report and literature review

Germline Multigene Panel Testing in Women With Invasive Lobular Cancer